Clonal relationships between epidermotropic metastatic melanomas and their primary lesions: A loss of heterozygosity and X-chromosome inactivation-based analysis

Modern Pathology

Volumn 20, Issue 8, 2007, Pages 821-827

  Bahrami, Soon ^a   Cheng, Liang ^a   Wang, Mingsheng ^a   Jones, Timothy D ^a   Malone, Janine C ^b   Billings, Steven D ^a,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Louisville School of Medicine   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Clonality; Cutaneous neoplasia; Epidermotropic metastases; Loss of heterozygosity; Melanoma; X chromosome inactivation

Indexed keywords

ALPHA INTERFERON; DNA; DNA MARKER; FORMALDEHYDE; PARAFFIN;

ADULT; AGED; ALLELE; ARTICLE; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; EPIDERMOTROPIC METASTATIC MELANOMA; FEMALE; GENE INACTIVATION; GENE LOCUS; HETEROZYGOSITY; HUMAN; LASER CAPTURE MICRODISSECTION; MALE; MELANOMA; METASTASIS; PRIORITY JOURNAL; TISSUE SECTION; X CHROMOSOME;

EID: 34447554522     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800833     Document Type: Article

References (42)

1. Balch CM, Soong SJ, Atkins MB, et al. An evidence based staging system for cutaneous melanoma. CA Cancer J Clin 2004;54:131-149.
2. Balch CM, Buzaid AC, Soong SJ, et al. New TNM melanoma staging system: linking biology and natural history to clinical outcomes. Semin Surg Oncol 2003;21:43-52.
3. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001;19:3635-3648.
4. Kornberg R, Harris M, Ackerman AB. Epidermotropically metastatic malignant melanoma: differentiating malignant melanoma metastatic to the epidermis from malignant melanoma primary in the epidermis. Arch Dermatol 1978;114:67-69.
5. White WL, Hitchcock MG. Dying dogma: the pathological diagnosis of epidermotropic metastatic malignant melanoma. Semin Diagn Pathol 1998;15:176-188.
6. Heenan PJ, Clay CD. Epidermotropic metastatic melanoma simulating multiple primary melanomas. Am J Dermatopathol 1991;13:396-402.
7. Gerami P, Shea C, Stone MS. Angiotropism in epidermotropic metastatic melanoma: another clue to the diagnosis. Am J Dermatopathol 2006;28:429-433.
8. Warner TF, Gilbert EF, Ramirez G. Epidermotropism in melanoma. J Cutan Pathol 1980;7:50-54.
9. Jackson R. Epidermotropic malignant melanoma: the distinction between metastatic and new primary lesions in the skin. Can J Surg 1984;27:533-535.
10. Hayashi H, Kawashima T, Hosokawa K, et al. Epidermotropic metastatic malignant melanoma with a pedunculated appearance. Clin Exp Dermatol 2003;28:666-680.
11. Abernethy JL, Soyer HP, Kerl H, et al. Epidermotropic metastatic malignant melanoma simulating melanoma in situ: a report of 10 examples from two patients. Am J Surg Pathol 1994;18:1140-1149.
12. Bengoechea-Beeby MP, Velasco-Oses A, Fernandez FM, et al. Epidermotropic metastatic melanoma: are the current histologic criteria adequate to differentiate primary from metastatic melanoma? Cancer 1993;72:1909-1913.
13. Fidler IJ, Kripke ML. Metastasis results from preexisting variant cells within a malignant tumor. Science 1977;197:893-895.
14. Fidler IJ. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. clowes memorial award lecture. Cancer Res 1990;50:6130-6138.
15. Heppner GH. Tumor heterogeneity. Cancer Res 1984;44:2259-2265.
16. Konemann S, Schuck A, Malath J, et al. Cell heterogeneity and subpopulations in solid tumors characterized by simultaneous immunophenotyping and DNA content analysis. Cytometry 2000;41:172-177.
17. Nicolson GL. Generation of phenotypic diversity and progression in metastatic tumor cells. Cancer Metastasis Rev 1984;3:25-42.
18. Boni R, Matt D, Voetmeyer A, et al. Chromosomal allele loss in primary cutaneous melanoma is heterogeneous and correlates with proliferation. J Invest Dermatol 1998;110:215-217.
19. Morita R, Fujimoto A, Hatta N, et al. Comparison of genetic profiles between primary melanomas and their metastases reveals genetic alterations and clonal evolution during progression. J invest Dermatol 1998;111:919-924.
20. Bogdan I, Xin H, Burg G, et al. Heterogeneity of allelic deletions within melanoma metastases. Melanoma Res 2001;11:349-354.
21. Rao UNM, Jones MW, Finkelstein SD. Genotypic analysis of primary and metastatic cutaneous melanoma. Cancer Genet Cytogenet 2003;140:37-44.
22. Takata M, Morita R, Takehara K. Clonal heterogeneity in sporadic melanomas as revealed by loss-of-heterozygosity analysis. Int J Cancer 2000;85:492-497.
23. Emmert-Buck MR, Bonner RF, Smith PD, et al. Laser capture microdissection. Science 1996;274:998-1001.
24. Bonner RF, Emmert-Buck MR, Cole K, et al. Laser capture microdissection: molecular analysis of tissue. Science 1997;278:1481-1483.
25. Brandli DW, Ulbright TM, Foster RS, et al. Stroma adjacent to metastatic mature teratoma after chemotherapy for testicular germ cell tumor is derived from the same progenitor cells as the teratoma. Cancer Res 2003;63:6063-6068.
26. Kernek KM, Ulbright TM, Zhang S, et al. Identical allelic loss in mature teratoma and different histologic components of malignant mixed germ cell tumors of the testis. Am J Pathol 2003;163:2477-2484.
27. Cheng L, Shan A, Cheville JC, et al. Atypical adenomatous hyperplasia of the prostate: a premalignant lesion? Cancer Res 1998;58:389-391.
28. Cheng L, Song SY, Pretlow TG, et al. Evidence of independent origin of multiple tumors from patients with prostate cancer. J Natl Cancer Inst 1998;90:233-237.
29. Cheng L, Bostwick DG, Li G, et al. Allelic imbalance in the clonal evolution of prostate carcinoma. Cancer 1999;85:2017-2022.
30. Cheng L, Gu J, Eble JN, et al. Molecular genetic evidence for different clonal origin of components of human renal angiomyolipomas. Am J Surg Pathol 2001;25:1231-1236.
31. Gu J, Roth LM, Younger C, et al. Molecular evidence for the independent origin of extra-ovarian papillary serous tumors of low malignant potential. J Natl Cancer Inst 2001;93:1147-1152.
32. Emerson RE, Ulbright TM, Zhang S, et al. Nephroblastoma arising in a germ cell tumor of testicular origin. Am J Surg Pathol 2004;28:687-692.
33. McCarthy RP, Zhang S, Bostwick DG, et al. Molecular genetic evidence for different clonal origins of epithelial and stromal components of phyllodes tumor of the prostate. Am J Pathol 2004;4: 1395-1400.
34. Cheng L, MacLennan GT, Zhang S, et al. Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder. Cancer 2004;101:183-188.
35. Cheng L, Gu J, Ulbright TM, et al. Precise microdissection of human bladder carcinomas reveals divergent tumor subclones in the same tumor. Cancer 2002;94:104-110.
36. Paterson RF, Ulbright TM, MacLennan T, et al. Molecular genetic alterations in the laser-capture microdissected stroma adjacent to bladder carcinoma. Cancer 2003;98:1830-1836.
37. Slominski A, Wortsman J, Nickoloff B, et al. Molecular pathology of malignant melanoma. Am J Clin Pathol 1998;110:788-794.
38. Nakayama T, Taback B, Turner R, et al. Molecular clonality of in-transit melanoma metastasis. Am J Pathol 2001;158:1371-1378.
39. Katona TM, Jones TD, Wang M, et al. Genetically heterogeneous and clonally unrelated metastases may arise in patients with cutaneous melanoma. Am J Surg Pathol 2007 (in press).
40. Peris K, Keller G, Chimenti S, et al. Microsatellite instability and loss of heterozygosity in melanoma. J Invest Dermatol 1995;105:625-628.
41. Funk JO, Schiller PI, Barrett MT, et al. p16INK4a expression is frequently decreased and associated with 9p21 loss of heterozygosity in sporadic melanoma. J Cutan Pathol 1998;25:291-296.
42. Ariyanayagam-Baksh SM, Baksh FK, Swalsky PA, et al. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma. Mod Pathol 2003;16:992-995.